Casdin Capital, LLC has filed 17 insider transactions across 1 company since March 2024.
Most recent transaction: a purchase of 175000 shares of GeneDx Holdings Corp. ($WGS) on May 18, 2026.
Activity breakdown: 15 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock, par value $0.0001 per share | 175000 | $42.55 | 3,555,072.0000 | 28,904,590 | 5.18% | 0.61% |
| May 20, 2026 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock, par value $0.0001 per share | 140000 | $43.81 | 3,880,072.0000 | 28,904,590 | 3.74% | 0.48% |
| May 19, 2026 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock, par value $0.0001 per share | 185000 | $42.60 | 3,740,072.0000 | 28,904,590 | 5.20% | 0.64% |
| May 11, 2026 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Cash Settled Swap | 50000 | $0.00 | 850,000.0000 | 28,904,590 | 6.25% | 0.17% |
| May 8, 2026 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Cash Settled Swap | 300000 | $0.00 | 800,000.0000 | 28,904,590 | 60.00% | 1.04% |
| May 7, 2026 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Cash Settled Swap | 500000 | $0.00 | 500,000.0000 | 28,904,590 | 9999.99% | 1.73% |
| Aug. 22, 2025 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | S | Class A Common Stock | 500000 | $120.90 | 3,380,073.0000 | 28,068,274 | 12.89% | 1.78% |
| Aug. 1, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | J | Class A Common Stock | 413655 | $32.25 | 3,862,697.0000 | 0 | 11.99% | 0.00% |
| June 3, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock | 100000 | $20.82 | 3,832,697.0000 | 0 | 2.68% | 0.00% |
| June 4, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock | 30000 | $22.52 | 3,862,697.0000 | 0 | 0.78% | 0.00% |
| May 29, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock | 40000 | $21.07 | 3,732,697.0000 | 0 | 1.08% | 0.00% |
| May 24, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock | 144196 | $20.12 | 3,674,393.0000 | 0 | 4.08% | 0.00% |
| May 28, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock | 18304 | $20.61 | 3,692,697.0000 | 0 | 0.50% | 0.00% |
| May 23, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock | 7500 | $19.59 | 3,530,197.0000 | 0 | 0.21% | 0.00% |
| May 13, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock | 50000 | $23.31 | 3,522,697.0000 | 0 | 1.44% | 0.00% |
| March 4, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock | 40000 | $8.74 | 3,471,797.0000 | 0 | 1.17% | 0.00% |
| March 5, 2024 | GeneDx Holdings Corp. | $WGS | Casdin Capital, LLC | Director | P | Class A Common Stock | 900 | $8.83 | 3,472,697.0000 | 0 | 0.03% | 0.00% |